81_FR_58689 81 FR 58524 - National Cancer Institute; Notice of Closed Meetings

81 FR 58524 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 81, Issue 165 (August 25, 2016)

Page Range58524-58525
FR Document2016-20346

Federal Register, Volume 81 Issue 165 (Thursday, August 25, 2016) 
[Federal Register Volume 81, Number 165 (Thursday, August 25, 2016)]
[Notices]
[Pages 58524-58525]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-20346]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; PQ 11: Mechanisms by which standard-of-care therapies affect 
immunotherapy.
    Date: September 28, 2016.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W108, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W108, Rockville, MD 20892-9750, 240-276-6343, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Program Project II (P01).
    Date: October 4-5, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington DC/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Sanita Bharti, Ph.D., Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W618, 
Rockville, MD 20892-9750, 240-276-5909, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; PQ 1: Inhibition of tumor growth in pre-malignant fields.
    Date: October 13, 2016.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2W032/034, Rockville, MD 20850 (Telephone 
Conference Call).
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W108, Rockville, MD 20892-9750, 240-276-6343, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational R21: SEP-5.
    Date: October 14, 2016.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2E914, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W110, Rockville, MD 20892-9750, 240-276-6344, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Provocative Question 7.
    Date: October 25, 2016.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W236, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Dona Love, Ph.D., Scientific Review Officer, 
Special Review Branch, Division of Extramural Activities, National 
Cancer Institute, 9609 Medical Center Drive, Room 7W236, Rockville, 
MD 20892-9750, 240-276-5264, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Research Answers to NCI's Provocative Questions.
    Date: October 26, 2016.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 4W034, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Thomas A. Winters, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W412, 
Rockville, MD 20892-9750, 240-276-6386, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Core Infrastructure and Methodological Research for Cancer 
Epidemiology Cohorts.
    Date: November 1, 2016.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 6W034, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Thomas A. Winters, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W412, 
Rockville, MD 20892-9750, 240-276-6386, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational R21: SEP-2.
    Date: November 3-4, 2016.
    Time: 8:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Yisong Wang, Ph.D., Scientific Review Officer, 
Special Review Branch, Division of Extramural Activities, National 
Cancer Institute, 9609 Medical Center Drive, Room 7W240, Rockville, 
MD 20892-9750, 240-276-7157, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI R01/U01 Review.
    Date: November 3, 2016.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2E914, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program

[[Page 58525]]

Review Branch, Division of Extramural Activities, National Cancer 
Institute, 9609 Medical Center Drive, Room 7W110, Rockville, MD 
20892-9750, 240-276-6344, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational Exploratory/Developmental 
Studies (R21): SEP-1.
    Date: November 7-8, 2016.
    Time: 8:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW., Washington, DC 20015.
    Contact Person: Dona Love, Ph.D., Scientific Review Officer, 
Special Review Branch, Division of Extramural Activities, National 
Cancer Institute, 9609 Medical Center Drive, Room 7W236, Rockville, 
MD 20892-9750, 240-276-5264, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational R21: SEP-6.
    Date: November 9, 2016.
    Time: 8:30 a.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W608, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Wlodek Lopaczynski, MD, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W608, Rockville, MD 20892-9750, 240-276-6458, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: August 19, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-20346 Filed 8-24-16; 8:45 am]
 BILLING CODE 4140-01-P

58524 Federal Register / Vol. 81, No. 165 / Thursday, August 25, 2016 / Notices Name of Committee: National Institute of Agenda: To review and evaluate grant 7W236, Rockville, MD 20850 (Telephone General Medical Sciences Special Emphasis applications. Conference Call). Panel; Review of Support of Competitive Place: National Cancer Institute, Shady Contact Person: Dona Love, Ph.D., Research (SCORE) Applications. Grove, 9609 Medical Center Drive, Room Scientific Review Officer, Special Review Date: August 25, 2016. 7W108, Rockville, MD 20850 (Telephone Branch, Division of Extramural Activities, Time: 1:00 p.m. to 2:00 p.m. Conference Call). National Cancer Institute, 9609 Medical Agenda: To review and evaluate grant Contact Person: Clifford W. Schweinfest, Center Drive, Room 7W236, Rockville, MD applications. Ph.D., Scientific Review Officer, Special 20892–9750, 240–276–5264, Place: National Institutes of Health, Review Branch, Division of Extramural donalove@mail.nih.gov. Natcher Building, Room 3An.12N, 45 Center Activities, National Cancer Institute, 9609 Name of Committee: National Cancer Drive, Bethesda, MD 20892 (Telephone Medical Center Drive, Room 7W108, Institute Special Emphasis Panel; Research Conference Call). Rockville, MD 20892–9750, 240–276–6343, Answers to NCI’s Provocative Questions. Contact Person: Lisa A. Dunbar, Scientific schweinfestcw@mail.nih.gov. Date: October 26, 2016. Review Officer, Office of Scientific Review, Name of Committee: National Cancer Time: 11:00 a.m. to 5:00 p.m. National Institute of General Medical Institute Special Emphasis Panel; NCI Agenda: To review and evaluate grant Sciences, National Institutes of Health, 45 Program Project II (P01). applications. Center Drive, Room 3AN12, Bethesda, MD Date: October 4–5, 2016. Place: National Cancer Institute Shady 20892, 301–594–2849, dunbarl@mail.nih.gov. Time: 8:00 a.m. to 5:00 p.m. Grove, 9609 Medical Center Drive, Room This notice is being published less than 15 Agenda: To review and evaluate grant 4W034, Rockville, MD 20850 (Telephone days prior to the meeting due to the timing applications. Conference Call). limitations imposed by the review and Place: Hilton Washington DC/Rockville, Contact Person: Thomas A. Winters, Ph.D., funding cycle. 1750 Rockville Pike, Rockville, MD 20852. Scientific Review Officer, Special Review (Catalogue of Federal Domestic Assistance Contact Person: Sanita Bharti, Ph.D., Branch, Division of Extramural Activities, Program Nos. 93.375, Minority Biomedical Scientific Review Officer, Research Programs National Cancer Institute, 9609 Medical Research Support; 93.821, Cell Biology and Review Branch, Division of Extramural Center Drive, Room 7W412, Rockville, MD Biophysics Research; 93.859, Pharmacology, Activities, National Cancer Institute, 9609 20892–9750, 240–276–6386, Physiology, and Biological Chemistry Medical Center Drive, Room 7W618, twinter@mail.nih.gov. Research; 93.862, Genetics and Rockville, MD 20892–9750, 240–276–5909, Name of Committee: National Cancer Developmental Biology Research; 93.88, sanitab@mail.nih.gov. Institute Special Emphasis Panel; Core Minority Access to Research Careers; 93.96, Name of Committee: National Cancer Infrastructure and Methodological Research Special Minority Initiatives; 93.859, Institute Special Emphasis Panel; PQ 1: for Cancer Epidemiology Cohorts. Biomedical Research and Research Training, Inhibition of tumor growth in pre-malignant Date: November 1, 2016. National Institutes of Health, HHS) fields. Time: 1:00 p.m. to 4:00 p.m. Dated: August 19, 2016. Date: October 13, 2016. Agenda: To review and evaluate grant Time: 10:00 a.m. to 6:00 p.m. applications. Melanie J. Gray, Agenda: To review and evaluate grant Place: National Cancer Institute Shady Program Analyst, Office of Federal Advisory applications. Grove, 9609 Medical Center Drive, Room Committee Policy. Place: National Cancer Institute Shady 6W034, Rockville, MD 20850 (Telephone [FR Doc. 2016–20348 Filed 8–24–16; 8:45 am] Grove, 9609 Medical Center Drive, Room Conference Call). BILLING CODE 4140–01–P 2W032/034, Rockville, MD 20850 (Telephone Contact Person: Thomas A. Winters, Ph.D., Conference Call). Scientific Review Officer, Special Review Contact Person: Clifford W. Schweinfest, Branch, Division of Extramural Activities, DEPARTMENT OF HEALTH AND Ph.D., Scientific Review Officer, Special National Cancer Institute, 9609 Medical Review Branch, Division of Extramural Center Drive, Room 7W412, Rockville, MD HUMAN SERVICES Activities, National Cancer Institute, 9609 20892–9750, 240–276–6386, Medical Center Drive, Room 7W108, twinter@mail.nih.gov. National Institutes of Health Rockville, MD 20892–9750, 240–276–6343, Name of Committee: National Cancer schweinfestcw@mail.nih.gov. Institute Special Emphasis Panel; NCI National Cancer Institute; Notice of Closed Meetings Name of Committee: National Cancer Clinical and Translational R21: SEP–2. Institute Special Emphasis Panel; NCI Date: November 3–4, 2016. Pursuant to section 10(d) of the Clinical and Translational R21: SEP–5. Time: 8:00 a.m. to 3:00 p.m. Federal Advisory Committee Act, as Date: October 14, 2016. Agenda: To review and evaluate grant amended (5 U.S.C. App.), notice is Time: 11:00 a.m. to 5:00 p.m. applications. hereby given of the following meetings. Agenda: To review and evaluate grant Place: Bethesda Marriott, 5151 Pooks Hill applications. Road, Bethesda, MD 20814. The meetings will be closed to the Place: National Cancer Institute Shady Contact Person: Yisong Wang, Ph.D., public in accordance with the Grove, 9609 Medical Center Drive, Room Scientific Review Officer, Special Review provisions set forth in sections 2E914, Rockville, MD 20850 (Telephone Branch, Division of Extramural Activities, 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Conference Call). National Cancer Institute, 9609 Medical as amended. The grant applications and Contact Person: Robert E. Bird, Ph.D., Center Drive, Room 7W240, Rockville, MD the discussions could disclose Scientific Review Officer, Research Program 20892–9750, 240–276–7157, confidential trade secrets or commercial Review Branch, Division of Extramural yisong.wang@nih.gov. property such as patentable material, Activities, National Cancer Institute, 9609 Name of Committee: National Cancer and personal information concerning Medical Center Drive, Room 7W110, Institute Special Emphasis Panel; NCI R01/ Rockville, MD 20892–9750, 240–276–6344, U01 Review. individuals associated with the grant birdr@mail.nih.gov. Date: November 3, 2016. asabaliauskas on DSK3SPTVN1PROD with NOTICES applications, the disclosure of which Name of Committee: National Cancer Time: 12:00 p.m. to 5:00 p.m. would constitute a clearly unwarranted Institute Special Emphasis Panel; Provocative Agenda: To review and evaluate grant invasion of personal privacy. Question 7. applications. Name of Committee: National Cancer Date: October 25, 2016. Place: National Cancer Institute Shady Institute Special Emphasis Panel; PQ 11: Time: 12:00 p.m. to 2:00 p.m. Grove, 9609 Medical Center Drive, Room Mechanisms by which standard-of-care Agenda: To review and evaluate grant 2E914, Rockville, MD 20850 (Telephone therapies affect immunotherapy. applications. Conference Call). Date: September 28, 2016. Place: National Cancer Institute Shady Contact Person: Robert E. Bird, Ph.D., Time: 11:00 a.m. to 4:00 p.m. Grove, 9609 Medical Center Drive, Room Scientific Review Officer, Research Program VerDate Sep<11>2014 18:54 Aug 24, 2016 Jkt 238001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\25AUN1.SGM 25AUN1

Federal Register / Vol. 81, No. 165 / Thursday, August 25, 2016 / Notices 58525 Review Branch, Division of Extramural DEPARTMENT OF HEALTH AND Institutes of Health, may not conduct or Activities, National Cancer Institute, 9609 HUMAN SERVICES sponsor, and the respondent is not Medical Center Drive, Room 7W110, required to respond to, an information Rockville, MD 20892–9750, 240–276–6344, National Institutes of Health collection that has been extended, birdr@mail.nih.gov. revised, or implemented on or after Name of Committee: National Cancer Submission for OMB Review; 30-Day October 1, 1995, unless it displays a Institute Special Emphasis Panel; NCI Comment Request Health Information currently valid OMB control number. Clinical and Translational Exploratory/ National Trends Survey V (HINTS V) Developmental Studies (R21): SEP–1. (National Cancer Institute) In compliance with section Date: November 7–8, 2016. 3507(a)(1)(D) of the Paperwork Time: 8:00 a.m. to 2:00 p.m. AGENCY: National Institutes of Health. Reduction Act of 1995, the National Agenda: To review and evaluate grant ACTION: Notice. Institutes of Health (NIH) has submitted applications. to the Office of management and Budget Place: Embassy Suites at the Chevy Chase SUMMARY: In compliance with the (OMB) a request for review and Pavilion, 4300 Military Road NW., Paperwork Reduction Act of 1995, the approval of the information collection Washington, DC 20015. National Cancer Institute, the National listed below. Contact Person: Dona Love, Ph.D., Institutes of Health, has submitted to the Scientific Review Officer, Special Review Office of Management and Budget Proposed Collection: Health Branch, Division of Extramural Activities, (OMB) a request for review and Information National Trends Survey V National Cancer Institute, 9609 Medical approval of the information collection (HINTS V), OMB 0925–0538, Exp 04/30/ Center Drive, Room 7W236, Rockville, MD listed below. This proposed information 2016. REINSTATEMENT WITH 20892–9750, 240–276–5264, collection was previously published in CHANGE, National Cancer Institute donalove@mail.nih.gov. the Federal Register on June 6, 2016, (NCI), National Institutes of Health Name of Committee: National Cancer page 36316 and allowed 60-days for (NIH). Institute Special Emphasis Panel; NCI public comment. One public comment Need and Use of Information Clinical and Translational R21: SEP–6. was received. The purpose of this notice Collection: HINTS V will provide NCI Date: November 9, 2016. is to allow an additional 30 days for with a comprehensive assessment of the Time: 8:30 a.m. to 3:30 p.m. public comment. American public’s current access to and Agenda: To review and evaluate grant DATES: Comments regarding this use of information about cancer across applications. information collection are best assured the cancer care continuum from cancer Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room of having their full effect if received prevention, early detection, diagnosis, 7W608, Rockville, MD 20850 (Telephone within 30-days of the date of this treatment, and survivorship. The Conference Call). publication. content of the survey will focus on Contact Person: Wlodek Lopaczynski, MD, ADDRESSES: Written comments and/or understanding the degree to which Ph.D., Scientific Review Officer, Research suggestions regarding the item(s) members of the general population Program Review Branch, Division of contained in this notice, especially understand vital cancer prevention Extramural Activities, National Cancer regarding the estimated public burden messages. More importantly, this NCI Institute, 9609 Medical Center Drive, Room and associated response time, should be survey will couple knowledge-related 7W608, Rockville, MD 20892–9750, 240– directed to the: Office of Management questions with inquiries into the 276–6458, lopacw@mail.nih.gov. communication channels through which and Budget, Office of Regulatory Affairs, (Catalogue of Federal Domestic Assistance OIRA_submission@omb.eop.gov or by understanding is being obtained, and Program Nos. 93.392, Cancer Construction; fax to 202–395–6974, Attention: Desk assessment of cancer-related behavior. 93.393, Cancer Cause and Prevention The analyses enabled by the survey will Officer for NIH. Research; 93.394, Cancer Detection and allow NCI and the cancer Diagnosis Research; 93.395, Cancer FOR FURTHER INFORMATION CONTACT: To request more information on the communication community to refine Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; proposed project or to obtain a copy of communication priorities, identify 93.398, Cancer Research Manpower; 93.399, the data collection plans and deficits in cancer-related population Cancer Control, National Institutes of Health, instruments, contact: Bradford W. knowledge, and develop evidence-based HHS) Hesse, Ph.D., Project Officer, National strategies for selecting the most effective Cancer Institute, 9609 Medical Center channels to reach identified Dated: August 19, 2016. Drive, 3E610, Bethesda, MD 20892–9760 demographic population groups. Melanie J. Gray, or call non-toll free number 240–276– OMB approval is requested for 3 Program Analyst, Office of Federal Advisory 6721 or email your request, including years. There are no costs to respondents Committee Policy. your address to: hesseb@mail.nih.gov. other than their time. The total [FR Doc. 2016–20346 Filed 8–24–16; 8:45 am] SUPPLEMENTARY INFORMATION: The estimated annualized burden hours are BILLING CODE 4140–01–P National Cancer Institute, NCI, National 2,017. ESTIMATED ANNUALIZED BURDEN HOURS Number of Average time Number of Total annual Form name Type of respondent responses per per response asabaliauskas on DSK3SPTVN1PROD with NOTICES respondents burden hours respondent (in hours) Main Study ............................................................ Individual ....................... 3,500 1 30/60 1,750 Pilot Study ............................................................ Individual ....................... 533 1 30/60 267 Total ............................................................... ....................................... 4,033 4,033 ........................ 2,017 VerDate Sep<11>2014 18:54 Aug 24, 2016 Jkt 238001 PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 E:\FR\FM\25AUN1.SGM 25AUN1


Document Created: 2016-08-25 00:34:33
Document Modified: 2016-08-25 00:34:33
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesSeptember 28, 2016.
FR Citation81 FR 58524 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR